Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19
Status:
Completed
Trial end date:
2022-03-11
Target enrollment:
Participant gender:
Summary
This is open-labe randomized multicenter comparative Phase III study conducted in 12 medical
facilities. The objective of the study is to evaluate efficacy and safety of the drug
JCBC00101, capsules in the setting of pathogenetic and symptomatic therapy as compared to
standard therapy in outpatients with COVID-19.